Worsening economic downturn has shifted focus to helping unemployed pay for health insuranceWashington-In early September, it appeared that advocates of a new patients'bill of rights would see success, and lobbyists for business and insuranceorganizations who opposed the initiative were willing to settle for thebest deal they could get.
Vobramitamab duocarmazine continues to show promise in mCRPC
May 10th 2024Updated data from the phase 2 TAMARCK study continued to show safety and preliminary efficacy with the B7-H3–targeting antibody-drug conjugate vobramitamab duocarmazine in patients with metastatic castration-resistant prostate cancer.